Additionally, surrogate molecular subtypes based on the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) by immunohistochemistry were also suggested to distinguish the biological behavior of DCIS [5, 9, 10]. This evidence concerns the gene PGR and ductal breast carcinoma in situ.